55
Participants
Start Date
February 28, 2009
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
CX-4945 oral formulation
CX-4945 Capsules, Oral, Dose escalation study, Dose schedule: twice daily or four times daily for 21 consecutive days every 28 days.
RECRUITING
U T M D Anderson Cancer Center, Houston
RECRUITING
Front Range Cancer Specialists, Fort Collins
RECRUITING
Front Range Cancer Specialists, Loveland
RECRUITING
Mayo Clinic Arizona, Scottsdale
Lead Sponsor
Cylene Pharmaceuticals
INDUSTRY